Skip to content

The protective effect of ßblocker (esmolol) on myocardial ischemia-reperfusion injury during open heart surgery in children

The protective effect of ßblocker (esmolol) on myocardial ischemia-reperfusion injury during open heart surgery in children

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000422
Enrollment
Unknown
Registered
2009-06-01
Start date
2007-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular septal defect

Interventions

Group B:No esmolol infusion during CPB
Group A:Esmolol was given via peripheral vein by continuous application (0.05mg/kg/min after intubation, 0.3 mg/kg/min during the extracorporeal circuit and 0.03-0.05mg/kg/min after weaning from bypas

Sponsors

Department of Anesthesiology, Union Hospital, Wuhan City, Hubei Province, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 72 Years

Inclusion criteria

Inclusion criteria: 1. Children undergoing primary ventricular septal defect repair; 2. Aged 2 to 72 months old; 3. Weight less than 25kg; 4. Signed informed consent/assent of subject, parent(s) or legal guardian as appropriate.

Exclusion criteria

Exclusion criteria: 1. No other cardiac malformations except ventricular septal defect; 2. No serious complications.

Design outcomes

Primary

MeasureTime frame
CK-MB, cTn;

Secondary

MeasureTime frame
CPB time, Cross-clamp time, heart spontaneous rebeating, Cumulative postoperative dosage of dopamine;

Countries

China

Contacts

Public ContactQingping Wu
wu_qingping1968@yahoo.com.cn+86 0 13971605283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026